Influenza

Overcoming Challenges to Create a Universal Influenza Vaccine

By

Jasenka Piljac Žegarac, PhD

Researchers from the National Institute of Allergy and Infectious Diseases are working to develop a universal influenza vaccine.

Safety and Efficacy: IV Zanamivir vs Oral Oseltamivir in Severe Influenza

By

Cindy Lampner

Intravenous zanamivir is as safe and effective as oral oseltamivir when used in patients with severe influenza.

Flu Activity Low in Southern Hemisphere From June to August 2020

There was very low influenza activity from June to August 2020 in the Southern Hemisphere.

COVID-19: Influenza Vaccine Key in Mitigating Healthcare Burden During Flu Season

By

Zahra Masoud

During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.

Pimodivir Influenza Development Program Discontinued

By

Brian Park, PharmD

The efficacy and safety of pimodivir, an inhibitor of influenza virus polymerase basic protein 2, was being investigated in two phase 3 studies.

Risk Factors for Cardiovascular Events in Adults Hospitalized With Influenza

Acute heart failure and acute ischemic heart disease are most common cardiovascular events in adults hospitalized with influenza.

School-Located Influenza Vaccine Intervention Beneficial

A school-located influenza vaccination intervention is associated with a reduction in the incidence of influenza hospitalization.

ACIP: Influenza Vaccination Recommendations for 2020-2021

By

Diana Ernst, RPh

The ACIP has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2020–2021 season.

Influenza Vaccination Underutilized in Populations at High-Risk for Complications

By

Jessica Nye, PhD

Influenza vaccinations were found to be underutilized among groups who are considered to be at high risk for complications from infection.

Influenza Vaccination Appears Lower in Dialysis Facilities With More Minority Patients

Influenza vaccination appears lower at US dialysis facilities with higher proportions of Black and Hispanic patients.